C.Q. Pharmaceutical Holding Stock Forum

The company's historical ROCE trend is uninspiring, and the increase in capital employed indicates that the business isn't investing in high return investments. The stock lacks multi-bagger traits, dampening investor optimism for trend improvement.

The company's low P/E ratio reflects expectations of persistent disappointing earnings performance. With bleak prospects for profitability, the P/E ratio could fall even lower as investors remain wary.

The company's low P/E ratio is due to expected further disappointing earnings. Without improved profitability, this could decrease further. Investors see no significant earnings improvement to justify a higher P/E ratio.